Shinoda, Yasuharu
82  Ergebnisse:
Personensuche X
?
 
?
 
?
 
?
 
?
7

An α-synuclein decoy peptide prevents cytotoxic α-synuclein..:

Fukui, Naoya ; Yamamoto, Hanae ; Miyabe, Moe...
Journal of Biological Chemistry.  296 (2021)  - p. 100663 , 2021
 
?
9

SAK3 Administration Improves Spine Abnormalities and Cognit..:

Izumi, Hisanao ; Kawahata, Ichiro ; Shinoda, Yasuharu..
International Journal of Molecular Sciences.  21 (2020)  11 - p. 3833 , 2020
 
?
10

Wildtype σ1 receptor and the receptor agonist improve ALS-a..:

Shinoda, Yasuharu ; Haga, Yudai ; Akagawa, Koichiro.
Journal of Biological Chemistry.  295 (2020)  51 - p. 17573-17587 , 2020
 
?
11

Novel fatty acid-binding protein 3 ligand inhibits dopamine..:

Haga, Hidaka ; Yamada, Ryo ; Izumi, Hisanao...
Pharmacology Biochemistry and Behavior.  191 (2020)  - p. 172891 , 2020
 
?
12

Anti-Epileptic Effects of FABP3 Ligand MF1 through the Benz..:

Yabuki, Yasushi ; Liu, Jiaqi ; Kawahata, Ichiro...
International Journal of Molecular Sciences.  21 (2020)  15 - p. 5525 , 2020
 
?
13

Analysis of binding affinity and docking of novel fatty aci..:

Shinoda, Yasuharu ; Wang, Yifei ; Yamamoto, Tetsunori..
Journal of Pharmacological Sciences.  143 (2020)  4 - p. 264-271 , 2020
 
?
14

Alzheimer's disease therapeutic candidate SAK3 is an enhanc..:

Fukunaga, Kohji ; Izumi, Hisanao ; Yabuki, Yasushi...
Journal of Pharmacological Sciences.  139 (2019)  2 - p. 51-58 , 2019
 
?
15

Combined citicoline and docosahexaenoic acid treatment impr..:

Nakazaki, Eri ; Yabuki, Yasushi ; Izumi, Hisanao...
Journal of Pharmacological Sciences.  139 (2019)  4 - p. 319-324 , 2019
 
1-15